WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong
· Delayed Price · Currency is HKD 36.38
+0.96 (2.71%)
Mar 10, 2026, 10:25 AM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 146.55 billion as of March 9, 2026. Its market cap has increased by 71.54% in one year.
Market Cap
146.55B
Enterprise Value
142.91B
Revenue
21.98B
Ranking
n/a
PE Ratio
32.70
Stock Price
36.38
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 146.55B, an increase of 357.42%. That is a compound annual growth rate of 19.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 144.54B |
| Sino Biopharmaceutical | 109.58B |
| Akeso | 98.84B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| BeOne Medicines AG | 261.29B |
| RemeGen | 59.85B |
| 3SBio | 53.95B |
| Shanghai Henlius Biotech | 37.50B |